Sign Up Today and Learn More About Chronicled Stock
Invest in or calculate the value of your shares in Chronicled or other pre-IPO companies through EquityZen's platform.
Chronicled Stock (CHRO)
Chronicled builds trust and automation in the life science industry, powered by blockchain.
About Chronicled Stock
Founded
2014
Headquarters
San Francisco, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Chronicled builds trust and automation in the life science industry, powered by blockchain. Based in San Francisco, Chronicled is the custodian of MediLedger, the primary blockchain-based network in the healthcare and life science industry that powers solutions to facilitate trust and automation between companies. Chronicled develops solutions for revenue management and supply chain on the MediLedger Network.
Chronicled Press Mentions
Stay in the know about the latest news on Chronicled
Blockchain in Manufacturing Market Growth Analysis with Investment Opportunities For 2024-2033
einpresswire • Oct 31, 2024
OSF HealthCare Joins MediLedger Network to Enhance Pricing Accuracy and Contract Management
newswire • Aug 04, 2024
NABP Acquires Patient Safety Tool From Chronicled, Inc.
morningstar • Jun 14, 2023
Vantage Solutions and Chronicled Join to Enhance QU4RTET Platform with MediLedger VRS Capabilities
prnewswire • Jul 12, 2022
AmerisourceBergen Partners with Chronicled to Optimize Pharmaceutical Chargeback Accuracy Using Blockchain-Powered Technology
biospace • Apr 22, 2022
Chronicled Management
Leadership team at Chronicled
Co-Founder
Ryan Orr
CTO and Co-Founder
Maurizio Greco
Join now and verify your accreditation status to gain access to:
- Chronicled Current Valuation
- Chronicled Stock Price
- Chronicled Management
- Available deals in Chronicled and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Chronicled Cap Table and Funding History by Share Class and Liquidity Preferences
- Chronicled Revenue and Financials
- Chronicled Highlights
- Chronicled Business Model
- Chronicled Risk Factors
- Chronicled Research Report from SACRA Research
Trading Chronicled Stock
How to invest in Chronicled stock?
Accredited investors can buy pre-IPO stock in companies like Chronicled through EquityZen funds. These investments are made available by existing Chronicled shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Chronicled stock?
Shareholders can sell their Chronicled stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
